Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-McDonald's, Apple, Model N, Neurocrine, HD Supply, AMD

Tue, 10th Sep 2013 12:29

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday:

FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS

U.S. stock index futures rose, putting the S&P 500 on trackfor a sixth day of gains, following another batch of rosyeconomic data out of China and as expectations eased about aWestern military strike against Syria. S&P 500 futures were up 0.65 percent, Dow Jones industrial average futures were up 0.62 percent, and Nasdaq 100 futures wereup 0.7 percent.

** APPLE INC, Monday close $506.17, up 0.5 pctpremarket

Apple is expected to introduce a cheaper version of theiPhone on Tuesday, bringing one of the industry's costliestsmartphones within reach of the masses in poorer emergingmarkets.

** MCDONALD'S CORP, Monday close $96.45, up 1 pctpremarket

The fast food chain reported a better-than-expected 1.9percent rise in global sales at established restaurants inAugust, boosted by stronger sales in Europe.

** ADVANCED MICRO DEVICES INC, Monday close $3.69,up 2 pct premarket

The chipmaker, targeting new markets as personal computersales decline, unveiled chips designed to run slot machines,factory robots, airport signs, medical equipment and otherdevices.

** MODEL N INC, Monday close $14.73, down 38 pctpremarket

The revenue management software maker forecast revenue forthe year ending September 2014 below analysts' estimates onMonday. Raymond James, Stifel Nicolaus and JPMorgan cut their ratings on the stock on Tuesday.

Analysts at Stifel said the company did not clearlyarticulate a plan to cut expenses. Raymond James analysts said areturn to revenue growth could be delayed well into 2015 unlessthe company quickly improved sales execution.

** NEUROCRINE BIOSCIENCES INC, Monday close $16.70,down 28 pct premarket

The company said on Monday that a lower dose of itsexperimental drug to treat a rare movement disorder did not meetthe main goal of a mid-stage clinical study. Cowen and Co cut its price target on the stock to $19 from $20while MKM Partners cut its target to $13.50 from $17.00 andOppenheimer to $15 from $19.

** HD SUPPLY HOLDINGS INC, Monday close $24.74, down9.5 pct premarket

The construction products supplier reported a widerquarterly loss for the second quarter due to expenses associatedwith debt restructuring. The company also forecast fiscal 2013results below analysts' estimates.

** STARWOOD PROPERTY TRUST INC, Monday close$25.04, down 4 pct premarket

The company, which finances and manages commercial mortgageloans, said it was offering 25 million shares in an underwrittenpublic offering.

** L&L ENERGY INC, Monday close $2.89, up 15 pctafter market

The coal miner's first-quarter profit more than doubled asproduction was boosted by the acquisition of two mines in Chinain November. Production rose 54 percent to 228,000 tons in thequarter.

** FIVE BELOW INC, Monday close $41.04, up 14 pctafter market

The specialty value retailer reported better-than-expectedresults for the second quarter due to a 6.6 percent increase insame-store sales. The company also raised its full-year earningsand revenue forecast.

** PVH CORP, Monday close $132.11, down 4.4 pctafter market

The maker of Calvin Klein and Tommy Hilfiger clothes gave athird-quarter sales and profit forecast that was below analysts'estimates. The company characterized the global environment as"challenging".

** BLACKBERRY LTD, Monday close $11.53, down 4 pctpremarket

The Canadian company's biggest shareholder has approachedseveral large Canadian investment funds about forging a deal totake the smartphone maker private, but the proposal is still "anairy-fairy, 'what if' kind of thing," according to a source withdirect knowledge of the situation.

** GLAXOSMITHKLINE PLC, Monday close $50.46, down 1pct premarket

The threat of generic copies of the company's best-sellinglung drug Advair finally making it to the market in the UnitedStates hit confidence in the drugmaker.

** MICROSOFT CORP, Monday close $31.65, up 1 pctpremarket

At least three of the top 20 investors in the company want aturnaround expert to succeed Steve Ballmer as chief executive.They have urged the technology giant's board to consider FordMotor Co Chief Executive Alan Mulally and ComputerSciences Corp Chief Executive Mike Lawrie for the job,several sources familiar with the matter said. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
17 Mar 2023 12:14

Deutsche Bank upgrades GSK to 'buy'

(Sharecast News) - Analysts at Deutsche Bank upgraded biopharmaceutical firm GSK from 'hold' to 'buy' on Friday as they updated estimates and made changes to their net present value assumptions.

Read more
17 Mar 2023 09:32

LONDON BROKER RATINGS: UBS likes LSEG; BofA lifts Weir Group

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
17 Mar 2023 07:53

LONDON BRIEFING: Emis takeover and BT Openreach get watchdog scrutiny

(Alliance News) - London's FTSE 100 is called to open higher on Friday, ending a tumultuous week in the green.

Read more
15 Mar 2023 06:00

How GSK plans to replenish its depleted medicine cabinet

GSK has overhauled R&D dept since Walmsley became CEO

*

Read more
14 Mar 2023 09:41

GSK lauds trial findings; asthma drug backed for review in China

(Alliance News) - GSK PLC said on Tuesday its asthma drug was accepted for review in China, while it also reported a trial for a drug to treat an infectious disease met its primary endpoint.

Read more
14 Mar 2023 09:35

GSK upbeat on meningitis vaccine candidate, asthma treatment

(Sharecast News) - Pharmaceutical giant GSK reported positive results from a phase three trial evaluating its MenABCWY combination vaccine candidate for meningitis on Tuesday.

Read more
13 Mar 2023 17:59

SVB shock could have chilling effect on British biotech sector

UK deal averted disaster for biotech start-ups

*

Read more
13 Mar 2023 16:26

SVB shock could have chilling effect on British biotech sector

UK deal averted disaster for biotech start-ups

*

Read more
9 Mar 2023 09:56

GSK expects US launch of RSV vaccine with no supply issues

LONDON, March 9 (Reuters) - GSK expects to launch its respiratory syncytial virus (RSV) vaccine in the U.S. this year without supply constraints and sees China as a major future market for the shot, a senior executive told Reuters.

Read more
9 Mar 2023 08:00

GSK set for US launch of RSV vaccine with no supply issues

LONDON, March 9 (Reuters) - GSK is prepared to launch its respiratory syncytial virus (RSV) vaccine in the U.S. this year without supply constraints and sees China as a major future market for the shot, the company’s head of vaccines research & development told Reuters.

Read more
6 Mar 2023 11:19

Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer

(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study reports relating to SRA737 to Sarerum's co-development partner CRT Pioneer Fund LP.

Read more
2 Mar 2023 11:13

TOP NEWS: Haleon revenue up; records loss due to GSK demerger costs

(Alliance News) - Haleon PLC on Thursday said revenue was up, as it declares its inaugural dividend following its GSK split.

Read more
2 Mar 2023 11:11

GSK spinoff Haleon has no deals on immediate horizon

LONDON, March 2 (Reuters) - Consumer healthcare group Haleon's Chief Executive Brian McNamara said on Thursday he does not expect to announce any acquisitions or divestments imminently, amid analyst concerns its 2023 cost forecasts could hit consensus profit estimates.

Read more
2 Mar 2023 09:48

LONDON BROKER RATINGS: Numis cuts BT to 'sell'; Citigroup cuts Babcock

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
2 Mar 2023 09:13

LONDON MARKET OPEN: CRH shares jump as it plans US primary listing

(Alliance News) - Stock prices in London were lower early Thursday, with the FTSE 100 index being spared from a steeper fall thanks to a jump in CRH shares and a weaker pound.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.